EUVIMEDAtrasti EUVIMED
EUVIMED · CrossrefJournal

Therapeutic Advances in Medical Oncology

ISSN 1758-8359 · SAGE Publications

Latest articles

  1. Plasma metabolomic profiling to predict durable response and survival with afatinib in EGFR-mutated non-small cell lung cancer: A prospective, multicenter, observational biomarker study

    Takeshi Honda, Kei Morikawa, Saori Takata, Hisashi Tanaka, Hidetoshi Itani, Kazuya Horiuchi, Ichiro Kawada, Hideyuki Nakagawa, Yoshiro Nakahara, Yoshitaka Seki, Akihiro Bessho, Nobumasa Takahashi, Kentaro Hayashi, Takeo Endo, Kiyoshi Takeyama, Toshiya Maekura, Nagio Takigawa, Akikazu Kawase, Makoto Endoh, Kenji Nemoto, Kazuma Kishi, Tomoko Fukuuchi, Yuko Iwasaki, Kenzo Soejima, Yusuke Okuma, Akira Togashi, Koji Ueda, Kenichi Yoshimura, Noriyuki Matsutani, Nobuhiko Seki, Daisuke Saigusa

    Published: 2026-11DOI: 10.1177/17588359261476047

  2. The evolving management of patients with extensive-stage small cell lung cancer in Switzerland: From regulatory access to bedside

    Nuria Neisy Mederos Alfonso, Ulrich Richter, Michael Thomas Mark, Sebastian Kraus, Alexander Meisel, Jana Pankovics, Martina Imbimbo, Patrizia Froesch, Kira-Lee Koster, Sabine Schmid, Sacha I. Rothschild, Alex Friedlaender, Asteria Nikolopoulou, Alexandre Huber, Danny Kupka, Karim Abdelhamid, Valérie Mosimann, Nabila Ferahta, May-Lucie Meyer, Solange Peters, Alessandra Curioni-Fontecedro

    Published: 2026-11DOI: 10.1177/17588359261500094

  3. Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancer

    Paul Cottu, Tomas Pascual, Jerôme Lemonnier, Huilin Hu, Estelle Roux, Roisin M. Connolly, Cynthia X. Ma, Antonio C. Wolff, Thayane Crestani, Pablo Tolosa, Juan M. Ferrero-Cafiero, Antonio Mulero-Sánchez, Fernando Salvador, Guillermo Villacampa, Joaquín Gavilá, Thibault de La Motte Rouge, Aleix Prat

    Published: 2026-08DOI: 10.1177/17588359261467380

  4. Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33—REGAL study

    Davide Bimbatti, Cecilia Nasso, Domiziana Aspden, Sebastiano Buti, Ludovica Antonj, Alessio Signori, Elena Verzoni, Cristian Lolli, Marilena Di Napoli, Martina Fanelli, Miriam De Lucia, Cristina Masini, Giandomenico Roviello, Daniela Arduini, Roberto Filippi, Alessia Mennitto, Mariella Sorarù, Giovanni Bozza, Luigi Formisano, Carlo Messina, Lucia Bonomi, Annalisa Guida, Emanuela Fantinel, Sarah Scagliarini, Maria Giuseppa Vitale, Silvia Chiellino, Brigida Anna Maiorano, Filippo Maria Deppieri, Paolo Andrea Zucali, Alessia Cavo, Claudia Caserta, Francesca La Russa, Vincenza Conteduca, Francesca Maines, Silvia Zai, Francesco Pierantoni, Massimiliano Icardi, Pasquale Rescigno, Fabrizio Di Costanzo, Giuseppe Luigi Banna

    Published: 2026-08DOI: 10.1177/17588359261470598

Volumes

2026 · 2202025 · 2782024 · 2332023 · 1802022 · 1852021 · 1662020 · 2372019 · 1172018 · 772017 · 632016 · 402015 · 282014 · 262013 · 292012 · 312011 · 302010 · 302009 · 16

Jūsų darbui tinkamos žinios.

Nuo nemokamos pradžios ir asmeninės literatūros paieškos iki viso Research Suite.

Peržiūrėti tarifus →

Ar įtraukti visi leidėjų pilnieji tekstai?

Ne. Bibliografiniai įrašai, santraukos ir pilnieji tekstai yra skirtingas turinys. Ar pilnasis tekstas prieinamas, priklauso nuo šaltinio, Open Access ir jūsų turimų licencijų. EUVIMED planas nepakeičia papildomų leidėjų teisių.